Add Company
Join Now

IncellDx Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

  • IncellDx's estimated annual revenue is currently $2.3M per year.(i)
  • IncellDx's estimated revenue per employee is $98,000

Employee Data

  • IncellDx has 23 Employees.(i)
  • IncellDx grew their employee count by -8% last year.

IncellDx's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
Founder and VP MarketingReveal Email/Phone
3
Manager / VP Product DevelopmentReveal Email/Phone
4
CEOReveal Email/Phone
5
VP R&D / Technical ServicesReveal Email/Phone
6
Chief Technical Officer, Head Technical OperationsReveal Email/Phone
7
Director Financial OperationsReveal Email/Phone
8
Chief Commercial OfficerReveal Email/Phone
9
Business Development Manager/ USReveal Email/Phone
10
Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M17N/AN/AN/A
#2
$0.6M80%N/AN/A
#3
$13.2M946%N/AN/A
#4
$78.4M4410%$6.8MN/A
#5
$12M86-1%N/AN/A
#6
$66.1M372-3%$131.5MN/A
#7
$0.6M8-50%N/AN/A
#8
$0.3M433%N/AN/A
#9
$0.6M9N/AN/AN/A
#10
$2.6M27N/AN/AN/A
Add Company

What Is IncellDx?

IncellDx is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a time. By combining molecular diagnostics with high throughput cellular analysis, we focus on critical life threatening diseases such as COVID-19, HIV/AIDs, lung cancer, breast cancer, bladder cancer, HPV/cervical cancer, head and neck cancer, ovarian cancer, hepatitis, and organ transplant infections. Our proprietary diagnostic method provides specific molecular details about each and every cell. This technology now made available through IncellDx, is capable of revolutionizing the field of molecular diagnostics, one cell at a time.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$2.3M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A23-4%N/A
#2
$2.3M23-8%N/A
#3
$1.9M24-23%$80M
#4
$1.8M260%N/A
#5
$4.3M28-12%N/A